New Zealand - English - Medsafe (Medicines Safety Authority)

max health limited - levetiracetam 500mg;   - film coated tablet - 500 mg - active: levetiracetam 500mg   excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch microcrystalline cellulose opadry yellow amb 84f82508 povidone purified talc - indicated for: - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation; - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy; - add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme); and - add-on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (ige).

New Zealand - English - Medsafe (Medicines Safety Authority)

max health limited - levetiracetam 750mg;   - film coated tablet - 750 mg - active: levetiracetam 750mg   excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch microcrystalline cellulose opadry pink amb 84f84674 povidone purified talc - indicated for: - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation; - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy; - add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme); and - add-on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (ige).

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - pantoprazole - gastro-resistant tablet - 20 milligram(s) - proton pump inhibitors; pantoprazole

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - levetiracetam - film-coated tablet - 500 milligram(s) - other antiepileptics; levetiracetam

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - levetiracetam - film-coated tablet - 1000 milligram(s) - other antiepileptics; levetiracetam

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - levetiracetam - film-coated tablet - 250 milligram(s) - other antiepileptics; levetiracetam

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - pantoprazole sodium sesquihydrate - gastro-resistant tablet - 20 milligram(s) - proton pump inhibitors; pantoprazole

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - pantoprazole sodium sesquihydrate - gastro-resistant tablet - 40 milligram(s) - proton pump inhibitors; pantoprazole

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - rizatriptan - tablet - 5 milligram(s) - selective serotonin (5ht1) agonists; rizatriptan

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - rizatriptan - oral lyophilisate - 5 milligram(s) - selective serotonin (5ht1) agonists; rizatriptan